News
Novo Nordisk's dropping share price spells the end for CEO
Novo Nordisk's chief executive Lars Fruergaard Jørgensen is stepping down by "mutual agreement" with the company's board.
News
Incyte's PD-1 drug brings immunotherapy to anal cancer
Incyte has broken new ground in immuno-oncology, getting FDA approval for its Zynyz drug as a treatment for anal cancer
News
Datavant, Aetion merger creates real-world data force
Datavant and Aetion merger promises "faster, more actionable" real-world data insights across pharma's clinical and commercial lifecycle.
News
MSD adds new indication for Welireg in rare tumours
MSD's oral HIF-2 alpha inhibitor Welireg has a third FDA approval, becoming the first oral treatment for a rare solid tumour PPGL or 'pheo para'.
News
AbbVie bags first approval for cancer ADC Emrelis
AbbVie has claimed its first global regulatory approval, from the FDA, for its C-met-targeting lung cancer ADC Emrelis.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
